Month: May 2021

Local bank ranked #86 in 2021, up from #105 in 2020 CORTLAND, Ohio, May 27, 2021 (GLOBE NEWSWIRE) — Cortland Bancorp. (NASDAQ: CLDB), the bank holding company of The Cortland Savings and Banking Company, today announced that, for the third straight year, it was again named to American Banker magazine’s Top 200 Publicly Traded Community Banks and Thrifts. In its May 2021 issue, American Banker ranked Cortland Bancorp 86th on the list of top performing publicly traded community banks. This continues the Bank’s upward growth trajectory after ranking as #105 on last year’s list and #134 in 2019. The rankings are based on three-year average return on equity (ROE) as of the end of the previous year. “It is always a great honor to be recognized by American Banker,” said James M. Gasior, President and Chief Executive Officer. “This type...

Primary Mortgage Market Survey®U.S. weekly average mortgage rates as of May 27, 2021.MCLEAN, Va., May 27, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing that the 30-year fixed-rate mortgage (FRM) averaged 2.95 percent. “Mortgage rates are down below three percent, continuing to offer many homeowners the potential to refinance and increase their monthly cash flow,” said Sam Khater, Freddie Mac’s Chief Economist. “In fact, homeowners who refinanced their 30-year fixed-rate mortgage in 2020 saved more than $2,800 dollars annually. Substantial opportunity continues to exist today, as nearly $2 trillion in conforming mortgages have the ability to refinance and reduce their interest rate by at least half a percentage point.” News Facts30-year...

WAKEFIELD, Mass., May 27, 2021 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces that patient enrollment in the Company’s 120-patient, Phase 2 clinical trial of Brilacidin for COVID-19 has reached 90 percent and that the Company anticipates full enrollment to be completed in approximately two weeks. Innovation Pharma is developing Brilacidin for treatment of moderate-to-severe COVID-19 in hospitalized patients under U.S. FDA Fast Track designation (see NCT04784897). The Phase 2 study is a randomized, double-blind, placebo-controlled clinical trial evaluating Brilacidin, a synthetic, non-peptidic small molecule drug candidate in a new class of compounds called defensin-mimetics, at domestic and international sites. The Company intends to provide...

CINCINNATI, May 27, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today participation in two upcoming investor conferences. Jack Kenny, Chief Executive Officer, will participate in a live, virtual fireside chat at the 41st Annual William Blair Growth Stock Conference on Wednesday, June 2, 2021 at 4:20 PM ET. Jack Kenny will also pre-record a presentation for the Jefferies Virtual Healthcare Conference which will be webcast on Friday, June 4, 2021 at 2:00 PM ET. Jack Kenny will be taking 1×1 meetings at the William Blair conference while Bryan Baldasare, Executive Vice President and Chief Financial Officer, and Charlie Wood, Vice President – Investor Relations, are taking 1×1 meetings at the Jefferies conference.   To access these presentations, go the Events & Presentations section of...

Company announcement – No. 33 / 2021 Zealand Pharma launches long-term incentive program for Zealand’s US based Corporate Management for 2021 Copenhagen, DK and Boston, MA, U.S., May 27, 2021 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, announces the implementation of a new share-based long-term incentive program for Zealand’s US based Corporate Management, in accordance with Zealand’s Remuneration Policy as adopted at the annual general meeting held on 15 April 2021. Zealand implemented the new incentive program to align with selected biotech peers, and is intended to drive long-term performance, align management’s and employees’ interests with those of Zealand’s shareholders,...

Miami, Florida, May 27, 2021 (GLOBE NEWSWIRE) — Coro Global Inc. (OTCQB: CGLO) announced today that its subsidiary Coro Corp., was granted a U.S. Money Transmitter license the State of Nevada. The company created CORO, a mobile payment app that allows anyone to exchange, send and save gold and dollars easily and securely. Coro Global is a Florida-based fintech on a mission to support people in understanding the value of using gold as resilient money. Coro is leveraging deep financial know-how and the new generation of distributed ledger technology (hashgraph) to build the infrastructure and tools for anyone to be able to buy gold in the smallest denominations and use it as easily as traditional currencies in their everyday lives. Nevada has a long history with gold. Its trajectory and wealth were built on prolific gold and silver...

Miami, FL, May 27, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Amazonas Florestal, Ltd (OTC: AZFL), a natural resources company dedicated to the processing of Industrial Hemp, High-CBD Hemp Products and the preservation of rainforest properties in Brazil that are eligible for REDD Plus Carbon Credits—a United Nations program—announced a recap of recent company material events. Recently the Company returned to current and compliant status with OTC Markets as a Pink Sheets Information Tier Company, having reorganized after a period of almost 3 years. Management is currently working diligently with hired accountants to complete a PCAOB audit of its records that should be completed in the month of July 2021. The completion of the PCAOB audit is the final requirement for the company to become eligible for funding facilities that...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 27, 2021 (GLOBE NEWSWIRE) — CubicFarm® Systems Corp. (TSXV:CUB) (“CubicFarms” or the “Company”), a local chain agricultural technology company, is pleased to announce that, due to strong demand, it has agreed with Raymond James Ltd. as sole bookrunner, on behalf of a syndicate of underwriters (collectively, the “Underwriters”), to increase the size of its previously announced $20 million “bought deal” offering of common shares. Pursuant to the upsized transaction terms, the Underwriters have agreed to purchase, on a “bought deal” basis, 16,296,297 common shares (the “Common Shares”) of the Company at a price of C$1.35 per Common Share (the “Issue Price”) for aggregate gross proceeds to the Company...